Detalles de la búsqueda
1.
Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials.
Lancet Oncol
; 25(6): 779-789, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38701815
2.
Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation.
Mod Pathol
; 37(3): 100423, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191122
3.
Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study.
J Minim Invasive Gynecol
; 31(3): 243-249.e2, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38171478
4.
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.
Br J Cancer
; 128(7): 1360-1368, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690721
5.
Introducing a novice surgeon to an experienced robotic gynaecological oncology team: An observational cohort study on the impact of a structured curriculum on outcomes of cervical cancer surgery.
Gynecol Oncol
; 178: 153-160, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37865051
6.
Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis.
Acta Oncol
; 62(11): 1479-1487, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37906286
7.
Upstaging by para-aortic lymph node dissection in patients with locally advanced cervical cancer: A systematic review and meta-analysis.
Gynecol Oncol
; 164(3): 667-674, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34969533
8.
Prognostic impact of waiting time between diagnosis and treatment in patients with cervical cancer: A nationwide population-based study.
Gynecol Oncol
; 165(2): 339-346, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35300853
9.
Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer.
Int J Gynecol Pathol
; 41(3): 220-226, 2022 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261899
10.
Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making.
Gynecol Oncol
; 161(3): 727-733, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33712276
11.
Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases.
Acta Oncol
; 60(10): 1342-1351, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34323648
12.
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
Int J Gynecol Cancer
; 30(12): 2002-2007, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046573
13.
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Lancet Oncol
; 20(9): 1273-1285, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31345626
14.
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 19(3): 295-309, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29449189
15.
Simulated dosimetric impact of online replanning for stereotactic body radiation therapy of lymph node oligometastases on the 1.5T MR-linac.
Acta Oncol
; 57(12): 1705-1712, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280631
16.
Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Acta Oncol
; 54(9): 1567-73, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26271799
17.
Multi-center dosimetric predictions to improve plan quality for brachytherapy for cervical cancer treatment.
Radiother Oncol
; 182: 109518, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736588
18.
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
J Clin Oncol
; 41(27): 4369-4380, 2023 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487144
19.
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Int J Radiat Oncol Biol Phys
; 116(4): 807-824, 2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36641039
20.
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors.
Radiother Oncol
; 181: 109501, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720348